Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy.

Howard, Susan J; Lestner, Jodi M; Sharp, Andrew; Gregson, Lea; Goodwin, Joanne; Slater, Joanne; Majithiya, Jayesh B; Warn, Peter A; Hope, William W

Howard, Susan J; Lestner, Jodi M; Sharp, Andrew; Gregson, Lea; Goodwin, Joanne; Slater, Joanne; Majithiya, Jayesh B; Warn, Peter A; Hope, William W.

Afiliación

Howard SJ; School of Translational Medicine, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Translational Research Facility in Respiratory Medicine, University Hospital of South Manchester National Health Service, Foundation Trust, Manchester, United Kingdom.

J Infect Dis ; 203(9): 1324-32, 2011 May 01.

Article en En | MEDLINE | ID: mdl-21357943

Asunto(s)

Antifúngicos/administración & dosificación; Antifúngicos/farmacocinética; Aspergilosis Pulmonar Invasiva/microbiología; Triazoles/administración & dosificación; Triazoles/farmacocinética; Animales; Modelos Animales de Enfermedad; Aspergilosis Pulmonar Invasiva/tratamiento farmacológico; Masculino; Ratones; Modelos Teóricos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triazoles / Aspergilosis Pulmonar Invasiva / Antifúngicos Límite: Animals Idioma: En Revista: J Infect Dis Año: 2011 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google